Clinical Research Directory
Browse clinical research sites, groups, and studies.
Intradermal Microbotulinum Toxin for Sebum Reduction and Facial Pore Improvement
Sponsor: Instituto de Oftalmología Fundación Conde de Valenciana
Summary
This study aims to evaluate the efficacy and safety of microdoses of botulinum toxin type A (microtoxin) for improving periocular skin quality and reducing fine wrinkles. Botulinum toxin is commonly used in aesthetic medicine; however, its use in microdoses has been proposed to achieve more natural results with fewer adverse effects. Participants with periocular rhytids will receive intradermal injections of diluted botulinum toxin. Clinical outcomes will include improvement in skin texture, wrinkle reduction, and patient satisfaction. Safety will be assessed by monitoring adverse events. The findings of this study may help determine whether microtoxin is an effective and safe option for minimally invasive periocular rejuvenation.
Official title: Effectiveness of Intradermal Microbotulinum Toxin for the Treatment of Seborrhea and Enlarged Facial Pores: A Prospective Before-and-After Pilot Study
Key Details
Gender
All
Age Range
18 Years - 35 Years
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2024-07-24
Completion Date
2024-11-24
Last Updated
2026-05-26
Healthy Volunteers
Yes
Interventions
Botulinum Toxin Type A (Dysport®)
Botulinum toxin type A is administered as intradermal microinjections (microtoxin) in the periocular region using a diluted formulation. The injections are performed using a standardized technique targeting superficial dermal layers to improve skin texture and reduce fine wrinkles while minimizing muscle paralysis.
Locations (1)
✔ Instituto de Oftalmología Fundación Conde de Valenciana IAP
Mexico City, Mexico